CAS No. 10161-87-2
Batch:
Purity:97.36
Chemical Structure
Check the
KRAS-533
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| CAS Number | 10161-87-2 | |
|---|---|---|
| Molecular Formula |
C13H16BrNO3 |
|
| Molecular Weight (MW) | 314.18 |
KRAS-533 is a small-molecule KRAS agonist that targets the GTP/GDP-binding pocket of KRAS. By preventing GTP hydrolysis, KRAS-533 promotes the accumulation of active GTP-bound KRAS. This activation triggers apoptotic and autophagic cell death pathways, ultimately leading to the suppression of mutant KRAS lung cancer in both in vitro and animal models. [1]
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
63 mg/mL
(200.52 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 15 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Note: Technical data last updated: Sep 1, 2026.